Related Experiment Video
Updated: May 31, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Pancreatic neoplasm in 2011: an update.
JOP : Journal of the Pancreas
|July 9, 2011
Summary
Pancreatic cancer remains a lethal disease with poor survival rates. While treatments for pancreatic neuroendocrine tumors have advanced, breakthroughs for pancreatic adenocarcinoma are limited.
Area of Science:
- Oncology
- Gastroenterology
- Medical Research
Background:
- Pancreatic cancer presents a significant therapeutic challenge with high mortality and a 5-year survival rate of only 5%.
- Current adjuvant chemotherapy, primarily gemcitabine-based, offers limited long-term survival benefits after resection.
- Metastatic pancreatic cancer is uniformly fatal, with a median survival of approximately 6 months.
Discussion:
- Gemcitabine is the standard first-line treatment for advanced pancreatic cancer, but adding erlotinib provides only a marginal survival benefit.
- There is a lack of consensus on second-line treatment for pancreatic adenocarcinoma.
- Progress has been made in treating advanced pancreatic neuroendocrine tumors (PNETs), with improved survival rates for certain subtypes.
Key Insights:
- Targeted therapies, including tyrosine kinase inhibitors (e.g., sunitinib) and mTOR inhibitors (e.g., everolimus), have been approved for PNETs.
- Treatment options for PNETs include surgery, chemoembolization, and cytotoxic therapy.
- Somatostatin analogues can prolong progression-free survival in metastatic midgut neuroendocrine tumors.
Outlook:
- Clinical trials offer opportunities for patients at all stages of pancreatic cancer.
- Further research is needed to develop more effective treatments for pancreatic adenocarcinoma.
- Advancements in targeted therapy and understanding of PNET biology offer hope for improved patient outcomes.
Related Concept Videos
01:27Acute Pancreatitis I: Introduction
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:25Acute Pancreatitis I: Introduction
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...